Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
81.20
-4.40 (-5.14%)
At close: Mar 27, 2026

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
126,102240,25094,36523,5407,528-
Market Cap Growth
-11.85%154.60%300.87%212.69%--
Enterprise Value
121,245233,73884,68522,6946,297-
Last Close Price
81.20155.0061.5019.136.11-
PS Ratio
3315.246316.212123.71604.64587.23-
PB Ratio
13.4025.539.736.296.47-
P/TBV Ratio
13.4025.539.736.296.47-
EV/Sales Ratio
-6145.021905.86582.91491.18-
Debt / Equity Ratio
000.000.010.030.06
Net Debt / Equity Ratio
-0.52-0.52-1.00-0.99-0.93-0.87
Net Debt / EBITDA Ratio
7.097.0913.887.483.582.60
Net Debt / FCF Ratio
10.9810.9818.148.534.214.44
Asset Turnover
0.000.000.010.020.010.03
Inventory Turnover
4.014.017.045.992.252.41
Quick Ratio
106.97106.97183.4250.4823.0415.00
Current Ratio
109.71109.71184.0250.8123.4115.26
Return on Equity (ROE)
-3.68%-3.68%-8.76%-19.92%-31.64%-64.89%
Return on Assets (ROA)
-4.59%-4.59%-6.59%-12.68%-20.53%-30.68%
Return on Capital Employed (ROCE)
-7.50%-7.50%-7.40%-13.70%-27.00%-34.30%
Earnings Yield
-0.28%-0.15%-0.62%-2.08%-3.80%-
FCF Yield
-0.35%-0.18%-0.56%-1.84%-3.41%-
Buyback Yield / Dilution
-7.93%-7.94%-15.40%-5.77%-27.35%-23.49%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.